Barclays’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $588K | Sell |
156,001
-109,352
| -41% | -$412K | ﹤0.01% | 2957 |
|
|
2025
Q1 | $1.2M | Buy |
265,353
+90,546
| +52% | +$410K | ﹤0.01% | 2352 |
|
|
2024
Q4 | $1.24M | Buy |
174,807
+14,656
| +9% | +$104K | ﹤0.01% | 2504 |
|
|
2024
Q3 | $1.3M | Buy |
160,151
+56,369
| +54% | +$459K | ﹤0.01% | 2455 |
|
|
2024
Q2 | $662K | Sell |
103,782
-721
| -0.7% | -$4.6K | ﹤0.01% | 2358 |
|
|
2024
Q1 | $787K | Sell |
104,503
-23,522
| -18% | -$177K | ﹤0.01% | 2570 |
|
|
2023
Q4 | $1.19M | Buy |
128,025
+74,816
| +141% | +$693K | ﹤0.01% | 2491 |
|
|
2023
Q3 | $538K | Buy |
53,209
+30,580
| +135% | +$309K | ﹤0.01% | 2506 |
|
|
2023
Q2 | $284K | Sell |
22,629
-6,570
| -23% | -$82.5K | ﹤0.01% | 2918 |
|
|
2023
Q1 | $341K | Buy |
29,199
+12,729
| +77% | +$149K | ﹤0.01% | 2876 |
|
|
2022
Q4 | $176K | Buy |
16,470
+12,054
| +273% | +$129K | ﹤0.01% | 3155 |
|
|
2022
Q3 | $43K | Sell |
4,416
-20,071
| -82% | -$195K | ﹤0.01% | 3699 |
|
|
2022
Q2 | $354K | Buy |
24,487
+4,582
| +23% | +$66.2K | ﹤0.01% | 2800 |
|
|
2022
Q1 | $521K | Buy |
+19,905
| New | +$521K | ﹤0.01% | 2773 |
|